A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-02-25) →
What happened
Enzychem Lifesciences updated a disclosed plan to sell treasury shares worth US$2.37M, about 4.1% of its market value.
For context, this equals about 4.1% of the company's market value.
| Disposal amount | US$2.37M |
|---|---|
| vs. market value | 4.1% |
| Filed | 2026-02-24, [Amended] Material event report (treasury share disposal) |
| Source | DART rcept 20260224003857 → open original filing |
Versions of this filing
- 2026-02-23Original
- 2026-02-24Amendment 1 (this page)
- 2026-02-25Amendment 2
Source: DART. Information only, not investment advice.